Pros | ![]() Beats FD returns for both 3Y & 5Y duration. | ![]() 5Y returns in the top 25% of the category. ![]() 3Y returns in the top 25% of the category. ![]() Among most bought funds within the category. | ||
Cons | ![]() 5Y returns in the bottom 25% of the category. ![]() 3Y returns in the bottom 25% of the category. | - |
INDMoney rank | 8/8 | 3/8 | ||
Category,Subcateogry | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 6 Years | 7 Years | ||
Fund Size | 845 Cr | 6162 Cr | ||
Min Investment | SIP ₹100 Lumpsum ₹1000 | SIP ₹100 Lumpsum ₹5000 | ||
Expense Ratio | 1.02% | 1.04% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 38 | 40 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (10.96%) Apollo Hospitals Enterprise Ltd (7.65%) Cipla Ltd (7.09%) Fortis Healthcare Ltd (5.15%) Abbott India Ltd (4.82%) | Sun Pharmaceuticals Industries Ltd (11.71%) Dr Reddy's Laboratories Ltd (9.47%) Divi's Laboratories Ltd (9.23%) Cipla Ltd (7.39%) Aurobindo Pharma Ltd (6.53%) | ||
No of Sectors | 2 | 3 | ||
Top 3 Sectors | Health (99.02%) Basic Materials (0.98%) | Health (97.35%) Basic Materials (1.5%) Financial Services (1.15%) | ||
Equity % | 97.86% | 95.88% | ||
Debt % | - | - | ||
P/E | 38.85 | 31.02 | ||
P/B | 6.07 | 4.22 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -0.78% | 0.9% | ||
3-Month Return | 3.58% | 3.1% | ||
6-Month Return | 12.57% | 17.43% | ||
1-Year Return | -1.91% | 4.55% | ||
3-Year Return | 24.86% | 30.56% | ||
5-Year Return | 17.17% | 21.73% |
Sharpe | 1.01 | 1.31 | ||
Alpha | -0.17 | 4.41 | ||
Beta | 0.96 | 0.94 | ||
Standard Deviation | 15.94 | 15.52 | ||
Information Ratio | -0.26 | 1.42 |
Description | Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Dhaval Shah,Dhaval Joshi | Dharmesh Kakkad,Sharmila D’mello |